28
Tue, Mar
10 New Articles

Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, and Saniona, a leading biotech company in the field of ion channel drug discovery, announced that they have entered into a research collaborationwith the objective to discover and develop novel compounds for the treatment of schizophrenia.

More Articles ...

Sign up via our free email subscription service to receive notifications when new information is available.
captcha